The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Valve Bioprostheses-Global Market Insights and Sales Trends 2025
Synopsis
Valve bioprostheses, also known as tissue heart valves, are artificial heart valves made from biological materials such as animal tissues (e.g., porcine or bovine) or human cadaveric tissues. They are used to replace damaged or diseased heart valves, restoring proper blood flow and improving cardiac function.
The global Valve Bioprostheses market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Valve Bioprostheses in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Valve Bioprostheses market. Aortic, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Mitral segment is estimated at % CAGR for the next seven-year period.
The market for valve bioprostheses is influenced by factors such as the increasing prevalence of valvular heart diseases, advancements in tissue engineering, and the aging population. The demand for minimally invasive valve replacement procedures has also driven the market's growth.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Valve Bioprostheses, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Valve Bioprostheses market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Valve Bioprostheses market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Valve Bioprostheses sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Valve Bioprostheses covered in this report include Braile Biomedica, Colibri Heart Valve, Edwards Lifesciences, JenaValve, Labcor, Meril Life Sciences, pulmonX, LivaNova and Valtech, etc.
The global Valve Bioprostheses market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Braile Biomedica
Colibri Heart Valve
Edwards Lifesciences
JenaValve
Labcor
Meril Life Sciences
pulmonX
LivaNova
Valtech
Global Valve Bioprostheses market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Valve Bioprostheses market, Segment by Type:
Aortic
Mitral
Pulmonary
Tricuspid
Global Valve Bioprostheses market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Valve Bioprostheses manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Valve Bioprostheses in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Valve bioprostheses, also known as tissue heart valves, are artificial heart valves made from biological materials such as animal tissues (e.g., porcine or bovine) or human cadaveric tissues. They are used to replace damaged or diseased heart valves, restoring proper blood flow and improving cardiac function.
The global Valve Bioprostheses market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Valve Bioprostheses in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Valve Bioprostheses market. Aortic, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Mitral segment is estimated at % CAGR for the next seven-year period.
The market for valve bioprostheses is influenced by factors such as the increasing prevalence of valvular heart diseases, advancements in tissue engineering, and the aging population. The demand for minimally invasive valve replacement procedures has also driven the market's growth.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Valve Bioprostheses, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Valve Bioprostheses market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Valve Bioprostheses market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Valve Bioprostheses sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Valve Bioprostheses covered in this report include Braile Biomedica, Colibri Heart Valve, Edwards Lifesciences, JenaValve, Labcor, Meril Life Sciences, pulmonX, LivaNova and Valtech, etc.
The global Valve Bioprostheses market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Braile Biomedica
Colibri Heart Valve
Edwards Lifesciences
JenaValve
Labcor
Meril Life Sciences
pulmonX
LivaNova
Valtech
Global Valve Bioprostheses market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Valve Bioprostheses market, Segment by Type:
Aortic
Mitral
Pulmonary
Tricuspid
Global Valve Bioprostheses market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Valve Bioprostheses manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Valve Bioprostheses in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Valve Bioprostheses Market Overview
1.1 Valve Bioprostheses Product Overview
1.2 Valve Bioprostheses Market Segment by Type
1.2.1 Aortic
1.2.2 Mitral
1.2.3 Pulmonary
1.2.4 Tricuspid
1.3 Global Valve Bioprostheses Market Size by Type
1.3.1 Global Valve Bioprostheses Market Size Overview by Type (2018-2029)
1.3.2 Global Valve Bioprostheses Historic Market Size Review by Type (2018-2023)
1.3.3 Global Valve Bioprostheses Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Valve Bioprostheses Sales Breakdown by Type (2018-2023)
1.4.2 Europe Valve Bioprostheses Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Valve Bioprostheses Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Valve Bioprostheses Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Valve Bioprostheses Sales Breakdown by Type (2018-2023)
2 Global Valve Bioprostheses Market Competition by Company
2.1 Global Top Players by Valve Bioprostheses Sales (2018-2023)
2.2 Global Top Players by Valve Bioprostheses Revenue (2018-2023)
2.3 Global Top Players by Valve Bioprostheses Price (2018-2023)
2.4 Global Top Manufacturers Valve Bioprostheses Manufacturing Base Distribution, Sales Area, Product Type
2.5 Valve Bioprostheses Market Competitive Situation and Trends
2.5.1 Valve Bioprostheses Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Valve Bioprostheses Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Valve Bioprostheses as of 2022)
2.7 Date of Key Manufacturers Enter into Valve Bioprostheses Market
2.8 Key Manufacturers Valve Bioprostheses Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Valve Bioprostheses Status and Outlook by Region
3.1 Global Valve Bioprostheses Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Valve Bioprostheses Historic Market Size by Region
3.2.1 Global Valve Bioprostheses Sales in Volume by Region (2018-2023)
3.2.2 Global Valve Bioprostheses Sales in Value by Region (2018-2023)
3.2.3 Global Valve Bioprostheses Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Valve Bioprostheses Forecasted Market Size by Region
3.3.1 Global Valve Bioprostheses Sales in Volume by Region (2024-2029)
3.3.2 Global Valve Bioprostheses Sales in Value by Region (2024-2029)
3.3.3 Global Valve Bioprostheses Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Valve Bioprostheses by Application
4.1 Valve Bioprostheses Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Valve Bioprostheses Market Size by Application
4.2.1 Global Valve Bioprostheses Market Size Overview by Application (2018-2029)
4.2.2 Global Valve Bioprostheses Historic Market Size Review by Application (2018-2023)
4.2.3 Global Valve Bioprostheses Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Valve Bioprostheses Sales Breakdown by Application (2018-2023)
4.3.2 Europe Valve Bioprostheses Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Valve Bioprostheses Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Valve Bioprostheses Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Valve Bioprostheses Sales Breakdown by Application (2018-2023)
5 North America Valve Bioprostheses by Country
5.1 North America Valve Bioprostheses Historic Market Size by Country
5.1.1 North America Valve Bioprostheses Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Valve Bioprostheses Sales in Volume by Country (2018-2023)
5.1.3 North America Valve Bioprostheses Sales in Value by Country (2018-2023)
5.2 North America Valve Bioprostheses Forecasted Market Size by Country
5.2.1 North America Valve Bioprostheses Sales in Volume by Country (2024-2029)
5.2.2 North America Valve Bioprostheses Sales in Value by Country (2024-2029)
6 Europe Valve Bioprostheses by Country
6.1 Europe Valve Bioprostheses Historic Market Size by Country
6.1.1 Europe Valve Bioprostheses Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Valve Bioprostheses Sales in Volume by Country (2018-2023)
6.1.3 Europe Valve Bioprostheses Sales in Value by Country (2018-2023)
6.2 Europe Valve Bioprostheses Forecasted Market Size by Country
6.2.1 Europe Valve Bioprostheses Sales in Volume by Country (2024-2029)
6.2.2 Europe Valve Bioprostheses Sales in Value by Country (2024-2029)
7 Asia-Pacific Valve Bioprostheses by Region
7.1 Asia-Pacific Valve Bioprostheses Historic Market Size by Region
7.1.1 Asia-Pacific Valve Bioprostheses Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Valve Bioprostheses Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Valve Bioprostheses Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Valve Bioprostheses Forecasted Market Size by Region
7.2.1 Asia-Pacific Valve Bioprostheses Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Valve Bioprostheses Sales in Value by Region (2024-2029)
8 Latin America Valve Bioprostheses by Country
8.1 Latin America Valve Bioprostheses Historic Market Size by Country
8.1.1 Latin America Valve Bioprostheses Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Valve Bioprostheses Sales in Volume by Country (2018-2023)
8.1.3 Latin America Valve Bioprostheses Sales in Value by Country (2018-2023)
8.2 Latin America Valve Bioprostheses Forecasted Market Size by Country
8.2.1 Latin America Valve Bioprostheses Sales in Volume by Country (2024-2029)
8.2.2 Latin America Valve Bioprostheses Sales in Value by Country (2024-2029)
9 Middle East and Africa Valve Bioprostheses by Country
9.1 Middle East and Africa Valve Bioprostheses Historic Market Size by Country
9.1.1 Middle East and Africa Valve Bioprostheses Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Valve Bioprostheses Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Valve Bioprostheses Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Valve Bioprostheses Forecasted Market Size by Country
9.2.1 Middle East and Africa Valve Bioprostheses Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Valve Bioprostheses Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Braile Biomedica
10.1.1 Braile Biomedica Company Information
10.1.2 Braile Biomedica Introduction and Business Overview
10.1.3 Braile Biomedica Valve Bioprostheses Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Braile Biomedica Valve Bioprostheses Products Offered
10.1.5 Braile Biomedica Recent Development
10.2 Colibri Heart Valve
10.2.1 Colibri Heart Valve Company Information
10.2.2 Colibri Heart Valve Introduction and Business Overview
10.2.3 Colibri Heart Valve Valve Bioprostheses Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Colibri Heart Valve Valve Bioprostheses Products Offered
10.2.5 Colibri Heart Valve Recent Development
10.3 Edwards Lifesciences
10.3.1 Edwards Lifesciences Company Information
10.3.2 Edwards Lifesciences Introduction and Business Overview
10.3.3 Edwards Lifesciences Valve Bioprostheses Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Edwards Lifesciences Valve Bioprostheses Products Offered
10.3.5 Edwards Lifesciences Recent Development
10.4 JenaValve
10.4.1 JenaValve Company Information
10.4.2 JenaValve Introduction and Business Overview
10.4.3 JenaValve Valve Bioprostheses Sales, Revenue and Gross Margin (2018-2023)
10.4.4 JenaValve Valve Bioprostheses Products Offered
10.4.5 JenaValve Recent Development
10.5 Labcor
10.5.1 Labcor Company Information
10.5.2 Labcor Introduction and Business Overview
10.5.3 Labcor Valve Bioprostheses Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Labcor Valve Bioprostheses Products Offered
10.5.5 Labcor Recent Development
10.6 Meril Life Sciences
10.6.1 Meril Life Sciences Company Information
10.6.2 Meril Life Sciences Introduction and Business Overview
10.6.3 Meril Life Sciences Valve Bioprostheses Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Meril Life Sciences Valve Bioprostheses Products Offered
10.6.5 Meril Life Sciences Recent Development
10.7 pulmonX
10.7.1 pulmonX Company Information
10.7.2 pulmonX Introduction and Business Overview
10.7.3 pulmonX Valve Bioprostheses Sales, Revenue and Gross Margin (2018-2023)
10.7.4 pulmonX Valve Bioprostheses Products Offered
10.7.5 pulmonX Recent Development
10.8 LivaNova
10.8.1 LivaNova Company Information
10.8.2 LivaNova Introduction and Business Overview
10.8.3 LivaNova Valve Bioprostheses Sales, Revenue and Gross Margin (2018-2023)
10.8.4 LivaNova Valve Bioprostheses Products Offered
10.8.5 LivaNova Recent Development
10.9 Valtech
10.9.1 Valtech Company Information
10.9.2 Valtech Introduction and Business Overview
10.9.3 Valtech Valve Bioprostheses Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Valtech Valve Bioprostheses Products Offered
10.9.5 Valtech Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Valve Bioprostheses Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Valve Bioprostheses Industrial Chain Analysis
11.4 Valve Bioprostheses Market Dynamics
11.4.1 Valve Bioprostheses Industry Trends
11.4.2 Valve Bioprostheses Market Drivers
11.4.3 Valve Bioprostheses Market Challenges
11.4.4 Valve Bioprostheses Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Valve Bioprostheses Distributors
12.3 Valve Bioprostheses Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
